Items where Author is "Wilder-Smith, A"
Up a level |
Number of items: 20.
2018
Ariën, KK;
Wilder-Smith, A;
(2018)
Dengue vaccine: reliably determining previous exposure.
The Lancet Global health.
ISSN 2214-109X
DOI: https://doi.org/10.1016/S2214-109X(18)30295-X
Massad, E;
Amaku, M;
Coutinho, FAB;
Struchiner, CJ;
Burattini, MN;
Khan, K;
Liu-Helmersson, J;
Rocklöv, J;
Kraemer, MUG;
Wilder-Smith, A;
(2018)
Estimating the probability of dengue virus introduction and secondary autochthonous cases in Europe.
Scientific reports, 8 (1).
p. 4629.
ISSN 2045-2322
DOI: https://doi.org/10.1038/s41598-018-22590-5
Massad, E;
Amaku, M;
Coutinho, FAB;
Struchiner, CJ;
Lopez, LF;
Coelho, G;
Wilder-Smith, A;
Burattini, MN;
(2018)
The risk of urban yellow fever resurgence in Aedes-infested American cities.
Epidemiology and infection, 146 (10).
pp. 1219-1225.
ISSN 0950-2688
DOI: https://doi.org/10.1017/S0950268818001334
Item availability may be restricted.
O'Reilly, KM;
Lowe, R;
Edmunds, WJ;
Mayaud, P;
Kucharski, A;
Eggo, RM;
Funk, S;
Bhatia, D;
Khan, K;
Kraemer, MUG;
+8 more...
Wilder-Smith, A;
Rodrigues, LC;
Brasil, P;
Massad, E;
Jaenisch, T;
Cauchemez, S;
Brady, OJ;
Yakob, L;
(2018)
Projecting the end of the Zika virus epidemic in Latin America: a modelling analysis.
BMC medicine, 16 (1).
p. 180.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-018-1158-8
Paixao, ES;
Leong, WY;
Rodrigues, LC;
Wilder-Smith, A;
(2018)
Asymptomatic Prenatal Zika Virus Infection and Congenital Zika Syndrome.
Open forum infectious diseases, 5 (4).
ofy073.
ISSN 2328-8957
DOI: https://doi.org/10.1093/ofid/ofy073
Vannice, K;
Wilder-Smith, A;
Hombach, J;
(2018)
Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.
The New England journal of medicine.
ISSN 0028-4793
DOI: https://doi.org/10.1056/NEJMp1803433
Item availability may be restricted.
Vannice, KS;
Wilder-Smith, A;
Barrett, ADT;
Carrijo, K;
Cavaleri, M;
de Silva, A;
Durbin, AP;
Endy, T;
Harris, E;
Innis, BL;
+5 more...
Katzelnick, LC;
Smith, PG;
Sun, W;
Thomas, SJ;
Hombach, J;
(2018)
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.
Technical Report.
Elsevier.
DOI: https://doi.org/10.1016/j.vaccine.2018.02.062
Wilder-Smith, A;
(2018)
Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV.
Clinical microbiology and infection.
ISSN 1198-743X
DOI: https://doi.org/10.1016/j.cmi.2018.03.024
Item availability may be restricted.
Wilder-Smith, A;
(2018)
Serostatus-dependent performance of the first licensed dengue vaccine: implications for travelers.
Journal of travel medicine.
ISSN 1195-1982
DOI: https://doi.org/10.1093/jtm/tay057
Item availability may be restricted.
Wilder-Smith, A;
(2018)
Risk of Dengue in Travelers: Implications for Dengue Vaccination.
Current infectious disease reports, 20 (12).
p. 50.
ISSN 1523-3847
DOI: https://doi.org/10.1007/s11908-018-0656-3
Wilder-Smith, A;
Chang, CR;
Leong, WY;
(2018)
Zika in travellers 1947-2017: a systematic review.
Journal of travel medicine, 25 (1).
ISSN 1195-1982
DOI: https://doi.org/10.1093/jtm/tay044
Full text not available from this repository.
Wilder-Smith, A;
Massad, E;
(2018)
Estimating the number of unvaccinated Chinese workers against yellow fever in Angola.
BMC infectious diseases, 18 (1).
p. 185.
ISSN 1471-2334
DOI: https://doi.org/10.1186/s12879-018-3084-y
2017
Durbin, A;
Wilder-Smith, A;
(2017)
An update on Zika vaccine developments.
Expert review of vaccines.
ISSN 1476-0584
DOI: https://doi.org/10.1080/14760584.2017.1345309
Full text not available from this repository.
Goncalves, A;
Peeling, RW;
Chu, MC;
Gubler, DJ;
de Silva, AM;
Harris, E;
Murtagh, M;
Chua, A;
Rodriguez, W;
Kelly, C;
+1 more...
Wilder-Smith, A;
(2017)
Innovative and new approaches to laboratory diagnosis of Zika and dengue: a meeting report.
The Journal of infectious diseases.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jix678
Item availability may be restricted.
Massad, E;
Amaku, M;
Coutinho, FAB;
Struchiner, CJ;
Lopez, LF;
Wilder-Smith, A;
Burattini, MN;
(2017)
Estimating the size of Aedes aegypti populations from dengue incidence data: Implications for the risk of yellow fever outbreaks.
Infectious disease modelling, 2 (4).
pp. 441-454.
ISSN 2468-0427
DOI: https://doi.org/10.1016/j.idm.2017.12.001
Wilder-Smith, A;
(2017)
Yellow fever vaccination: estimating coverage.
The Lancet infectious diseases.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(17)30494-2
Wilder-Smith, A;
(2017)
Moving forward with Takeda's live chimeric tetravalent dengue vaccine.
The Lancet infectious diseases.
ISSN 1473-3099
DOI: https://doi.org/10.1016/S1473-3099(17)30165-2
Full text not available from this repository.
Wilder-Smith, A;
Longini, I;
Zuber, PL;
Bärnighausen, T;
Edmunds, WJ;
Dean, N;
Spicher, VM;
Benissa, MR;
Gessner, BD;
(2017)
The public health value of vaccines beyond efficacy: methods, measures and outcomes.
BMC medicine, 15 (1).
p. 138.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-017-0911-8
Wilder-Smith, A;
Preet, R;
Renhorn, KE;
Ximenes, RA;
Rodrigues, LC;
Solomon, T;
Neyts, J;
Lambrechts, L;
Willison, H;
Peeling, R;
+7 more...
Falconar, AK;
Precioso, AR;
Logan, J;
Lang, T;
Endtz, HP;
Erasmus, MC;
Massad, E;
(2017)
ZikaPLAN: Zika Preparedness Latin American Network.
Global health action, 10 (1).
p. 1398485.
ISSN 1654-9716
DOI: https://doi.org/10.1080/16549716.2017.1398485
2016
Young, B;
Zhao, X;
Cook, AR;
Parry, CM;
Wilder-Smith, A;
I-Cheng, MC;
(2016)
Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.
Vaccine, 35 (2).
pp. 212-221.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2016.11.013